Georgios Manousakis - Concepedia

Author

Georgios Manousakis

University of Minnesota ORCID

Also Known As

G. Manousakis, Georgios E Manousakis, Georgios Manousakis, Manousakis, Georgios, Samuel Maiser

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota Washington University in St. Louis University of Iowa Newcastle University Resonance Research (United States)

About

Georgios Manousakis is an author at University of Minnesota specializing in medicine, clinical trials, and rehabilitation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	382
2	Health Sciences	1	1	22
3	Public Health	1	1	49
4	Social Sciences	1	1	22
5	Applied Physiology	1	1	22

Georgios Manousakis

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study Timothy M. Miller, Alan Pestronk, William David, The Lancet Neurology	2013	603
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study James F. Howard, Saskia Bresch, Angela Genge, The Lancet Neurology MedicineSurgeryClinical TrialsGeneralised Myasthenia Gravis	2023	213
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Eugenio Mercuri, Juan J. Vílchez, Odile Boespflug‐Tanguy, The Lancet Neurology Duchenne Muscular DystrophyClinical TrialsPharmacotherapyMedicineNeuromusculoskeletal Disorder	2024	100
Multifocal radiculoneuropathy during ipilimumab treatment of melanoma Georgios Manousakis, James P. Koch, R. Brian Sommerville, Muscle & Nerve	2013	76
A first presentation of multiple sclerosis with concurrent COVID-19 infection Lisa E. Moore, Malik Ghannam, Georgios Manousakis eNeurologicalSci Virus EpidemiologyViral DiagnosticsNeurological DisorderCovid-19 EpidemiologyCovid-19	2020	49
Plasma Exchange After Initial Intravenous Immunoglobulin Treatment in Guillain-Barré Syndrome: Critical Reassessment of Effectiveness and Cost-Efficiency Malgorzata Oczko-Walker, Georgios Manousakis, Sijan Wang, Journal of Clinical Neuromuscular Disease	2010	45
Genotype–phenotype correlations in valosin-containing protein disease: a retrospective muticentre study Marianela Schiava, Chiseko Ikenaga, Rocío N. Villar‐Quiles, Journal of Neurology Neurosurgery & Psychiatry	2022	37
Phase <scp>2B</scp> randomized controlled trial of <scp>NP001</scp> in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses Robert G. Miller, Rongzhen Zhang, Paige M. Bracci, Muscle & Nerve	2022	29
Neurochemical correlates of functional decline in amyotrophic lateral sclerosis Ian Cheong, Dinesh K. Deelchand, Lynn E. Eberly, Journal of Neurology Neurosurgery & Psychiatry	2018	24
Randomized phase 2 study of<scp>ACE</scp>‐083, a<scp>muscle‐promoting</scp>agent, in facioscapulohumeral muscular dystrophy Jeffrey Statland, Craig Campbell, Urvi Desai, Muscle & Nerve	2022	24

Page 1